Literature DB >> 868079

Metabolic disposition of chlorambucil in rats.

C Mitoma, T Onodera, T Takegoshi, D W Thomas.   

Abstract

1. The metabolic dispositionof chlorambucil, 4-p-(di-2-chloroethyl)aminophenylbutyric acid, was studied in the rat. 2. After oral administration of [14C]chlorambucil to rats, plasma, liver, and kidney showed the highest concentration of 14C. After intravenous administration, plasma and kidney were heavily labelled. Although plasma contained as much as 10% of the administered dose in the first few hours after administration, the level decreased to 1% by 24 h. Elimination of radioactivity was mainly through the kidney. 3. Ten metabolites were isolated and characterized by mass spectrometry. Most metabolites had undergone oxidation on the butyric acid side-chain to form phenylacetic acid and benzoic acid derivatives. Spontaneous degradation products of [14C]chlorambucil were analysed and compared with the metabolites.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 868079     DOI: 10.3109/00498257709035779

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  7 in total

1.  Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.

Authors:  N H Greig; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards.

Authors:  D Godenèche; J C Madelmont; M F Moreau; R Plagne; G Meyniel
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  The pharmacokinetics of prednimustine and chlorambucil in the rat.

Authors:  D R Newell; C R Shepherd; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro.

Authors:  E Musch; M Malek; J Peter-Katalinic; H Egge; H Rink; B Lathan; E Riedel
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in mice.

Authors:  F Y Lee; P Coe; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Can food affect the bioavailability of chlorambucil in patients with haematological malignancies?

Authors:  C G Adair; J M Bridges; Z R Desai
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Toward hypoxia-selective DNA-alkylating agents built by grafting nitrogen mustards onto the bioreductively activated, hypoxia-selective DNA-oxidizing agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).

Authors:  Kevin M Johnson; Zachary D Parsons; Charles L Barnes; Kent S Gates
Journal:  J Org Chem       Date:  2014-07-25       Impact factor: 4.354

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.